hydralazine has been researched along with Prostatic Neoplasms in 2 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graça, I | 1 |
| Sousa, EJ | 1 |
| Costa-Pinheiro, P | 1 |
| Vieira, FQ | 1 |
| Torres-Ferreira, J | 1 |
| Martins, MG | 1 |
| Henrique, R | 1 |
| Jerónimo, C | 1 |
| Chuang, JC | 1 |
| Yoo, CB | 1 |
| Kwan, JM | 1 |
| Li, TW | 1 |
| Liang, G | 1 |
| Yang, AS | 1 |
| Jones, PA | 1 |
2 other studies available for hydralazine and Prostatic Neoplasms
| Article | Year |
|---|---|
Anti-neoplastic properties of hydralazine in prostate cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Humans; Hydralazine; Male; Prostatic Neoplasms; Vasodilator | 2014 |
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Transitional Cell; Catechin; Cell Line, Tum | 2005 |